Published July 22, 2010 | Version v1
Journal article Open

Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus

Description

We used an approach that we term ancestry-shift refinement mapping to investigate an association, originally discovered in a GWAS of a Chinese population, between rs2046210[T] and breast cancer susceptibility. The locus is on 6q25.1 in proximity to the C6orf97 and estrogen receptor α (ESR1) genes. We identified a panel of SNPs that are correlated with rs2046210 in Chinese, but not necessarily so in other ancestral populations, and genotyped them in breast cancer case:control samples of Asian, European, and African origin, a total of 10,176 cases and 13,286 controls. We found that rs2046210[T] does not confer substantial risk of breast cancer in Europeans and Africans (OR = 1.04, P = 0.099, and OR = 0.98, P = 0.77, respectively). Rather, in those ancestries, an association signal arises from a group of less common SNPs typified by rs9397435. The rs9397435[G] allele was found to confer risk of breast cancer in European (OR = 1.15, P = 1.2×10-3), African (OR = 1.35, P = 0.014), and Asian (OR = 1.23, P = 2.9×10-4) population samples. Combined over all ancestries, the OR was 1.19 (P = 3.9×10-7), was without significant heterogeneity between ancestries (Phet = 0.36) and the SNP fully accounted for the association signal in each ancestry. Haplotypes bearing rs9397435[G] are well tagged by rs2046210[T] only in Asians. The rs9397435[G] allele showed associations with both estrogen receptor positive and estrogen receptor negative breast cancer. Using early-draft data from the 1,000 Genomes project, we found that the risk allele of a novel SNP (rs77275268), which is closely correlated with rs9397435, disrupts a partially methylated CpG sequence within a known CTCF binding site. These studies demonstrate that shifting the analysis among ancestral populations can provide valuable resolution in association mapping.

Notes

Due to the large number of authors, only the first 20 and the University of Chicago authors are included on the above author list. Please download the article for the complete list of authors.

Files

journal.pgen.1001029.pdf

Files (2.9 MB)

Name Size Download all
Article
md5:c8c7ba664dfd83c2ec48afe9ca3d1bd5
369.1 kB Preview Download
md5:a04e050161f3cc12f3bd64ce0d97aa54
2.5 MB Preview Download

Additional details

Identifiers

DOI
10.1371/journal.pgen.1001029
Other
oai:uchicago.tind.io:10902

Funding

United States Army Medical Research and Materiel Command
W81XWH-08-1-0740
European Union
6th Framework Programme
European Union
7th Framework Programme
National Cancer Institute
R01 CA89085
National Cancer Institute
P50 CA125183-03
National Institutes of Health
R01 CA122340
National Cancer Institute
Specialized Program of Research Excellence award

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine
Center(s) or Institute(s)
Center for Clinical Cancer Genetics and Global Health